NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Abram Scientific

Abram Scientific

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.abramscientific.com/

Last Round

Series A

Feb 25, 2026

Total Funding Raised

$18.05M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Abram Scientific is a medical device company that develops a portable, rapid viscoelastic blood coagulation diagnostic platform for point-of-care use.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care diagnosticscoagulation testingmedtechPOC diagnosticshemostasis monitoringmedical deviceviscoelastic testingblood managementdiagnostic hardwaretrauma caredisposable assaysurgical diagnosticsclinical diagnosticsrazor-and-blade modelfield diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abram Scientific Comparables

Compare Abram Scientific with similar companies based on industry and business-model similarity.

Abram Scientific comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stasys Medical Corporation
88%
Perosphere Technologies Inc.
87%
Sienco, Inc.
83%

Abram Scientific Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 25, 2026
GrantApr 6, 2021
GrantJan 19, 2021

Key People

Founding team and executive leadership

Abhishek Ramkumar

CEO, Founder

Founding Team

Thomas Rota

Chief Financial Officer

Executive Team

Abram Scientific Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    $12M round led by Octapharma AG.

  • Apr 6, 2021

    $1M grant awarded by the National Science Foundation.

Abram Scientific Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abram Scientific Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abram Scientific's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range8
Year Founded2013
Last FundingFeb 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.